Phase IIb Multicenter Randomized Comparative Study of Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for Chronic Inflammatory Bowel Disease
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms PneumoMICI
- 17 Oct 2017 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 17 Oct 2017 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2021.
- 17 May 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2020.